Cargando…

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives

Parkinson’s disease (PD) is a neurodegenerative disease caused by loss of dopaminergic neurons in the midbrain. PD is clinically characterized by a variety of motor and nonmotor symptoms, and treatment relies on dopaminergic replacement. Beyond a common pathological hallmark, PD patients may present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magistrelli, Luca, Ferrari, Marco, Furgiuele, Alessia, Milner, Anna Vera, Contaldi, Elena, Comi, Cristoforo, Cosentino, Marco, Marino, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038729/ https://www.ncbi.nlm.nih.gov/pubmed/33917417 http://dx.doi.org/10.3390/ijms22073781

Ejemplares similares

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
por: Furgiuele, Alessia, et al.
Publicado: (2021)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
por: Comi, Cristoforo, et al.
Publicado: (2019)

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
por: Martini, Stefano, et al.
Publicado: (2023)

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016)

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine
por: De Pieri, Marco, et al.
Publicado: (2023)

Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals
por: Cosentino, Marco, et al.
Publicado: (2021)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
por: Storelli, Elisa, et al.
Publicado: (2019)

The prevention of falls in patients with Parkinson’s disease with in-home monitoring using a wearable system: a pilot study protocol
por: Campani, Daiana, et al.
Publicado: (2022)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
por: Cosentino, Marco, et al.
Publicado: (2022)

The spike hypothesis in vaccine-induced adverse effects: questions and answers
por: Cosentino, Marco, et al.
Publicado: (2022)

In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
por: Cosentino, Marco, et al.
Publicado: (2023)

Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease
por: De Groote, Evelien, et al.
Publicado: (2020)

Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives
por: Cosentino, Marco, et al.
Publicado: (2015)

Polymorphisms in dopamine‐associated genes and cognitive decline in Parkinson's disease
por: Bäckström, D., et al.
Publicado: (2017)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson’s disease
por: Wu, Jingjing, et al.
Publicado: (2022)

Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature
por: Ramesh, Sairam, et al.
Publicado: (2023)

The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
por: Cappellano, Giuseppe, et al.
Publicado: (2020)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson’s Disease
por: Shao, Peng, et al.
Publicado: (2016)

A nationwide web-based survey of a sample of Italian community pharmacists’ perceptions and opinions about online sales of medicines and falsified drugs
por: Lombardo, Simona, et al.
Publicado: (2019)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
por: Robertson, Brian D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_heo37kgeh7tfb7pcunl3poqch4